Equities

Uniphar PLC

UPR:LSE

Uniphar PLC

Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (GBX)348.00
  • Today's Change9.00 / 2.65%
  • Shares traded208.63k
  • 1 Year change71.43%
  • Beta0.9828
Data delayed at least 20 minutes, as of Feb 06 2026 16:37 GMT.
More ▼

Profile data is unavailable for this security.

About the company

Uniphar PLC is an Ireland-based diversified healthcare service company. The Company is focused on improving access to pharmaco-medical products and therapies. It operates through three divisions: Uniphar Medtech, Uniphar Pharma, and Uniphar Supply Chain & Retail. Its Uniphar Medtech division provides outsourced services, specifically sales, distribution, and support services to medical device manufacturers. Uniphar Pharma division operates a global business with valued services across the lifecycle of a pharmaceutical product. This division operates through on demand and pharma services business units. Uniphar Supply Chain & Retail division provides both pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and veterinary surgeons in Ireland. It operates a network of pharmacies under the Life, Allcare, Hickey’s and McCauleys brands. It also provides services and support that help independent community pharmacies.

  • Revenue in EUR (TTM)2.89bn
  • Net income in EUR66.31m
  • Incorporated1994
  • Employees3.51k
  • Location
    Uniphar PLC4045 Kingswood RoadCitywest Business ParkDUBLIN D24 V06KIrelandIRL
  • Phone+353 14687501Fax+353 14287776
  • Websitehttps://www.uniphar.ie/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		UPR:LSE since
announced		Transaction
value
Touchstore LtdAnnounced14 Jan 202614 Jan 2026Announced9,254.84%--
Data delayed at least 20 minutes, as of Feb 06 2026 16:37 GMT.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.